Scholars Central

Conference abstractPublished 19 Nov 2012

X-linked agammaglobulinemia (XLA) as a model disease for the development of molecular diagnostic and gene therapy for primary immunodeficiency

Authors: Yuk Yin Ng

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The X-linked agammaglobulinemia (XLA) is the one of the most common primary antibody deficiency in man. XLA is caused by mutations in the Bruton?s tyrosine kinase ( BTK ) gene and BTK mutations are responsible for 85% of all antibody deficiencies. Current treatments with intravenous immunoglobulin (IVIG) infusion and antibiotics are effective, however they are expensive and non-curative. We investigate whether stem cell-based gene therapy using the lentiviral vectors could provide a novel treatment option for XLA. Moreover, mutation analysis have never been applied for XLA in Turkey, therefore we incorpeated BTK mutation analysis to improve the diagnosis of XLA. Btk -/- mice engrafted with transduced cells showed correction of B-cell in bone marrow, spleen and blood. All treated mice exhibited the recovery serum immunoglobulins as well as responses to T cell-independent antigens. Moreover, transplantation into secondary Btk -/- recipients resulted in functional restoration of B cells and serum immunoglobulins, without any adverse effects. To validate the BTK mutation analysis, patients (n=14) with antibody deficiency were screened for BTK mutation. In seven patients, BTK mutations were confirmed by sequencing and all mutations have resulted in a premature stop codon and consequently lead to the absence the Btk protein. Interestingly in other seven patients, no BTK mutation was found indicating the high incidence of autosomal recessive agammaglobulinemia in Turkey. In conclusion, we demonstrated in the Btk -/- mouse model the feasibility of stem cell-based lentiviral gene therapy for XLA. Furthermore, we also conclude that BTK mutation analysis provides a significant improvement for XLA diagnosis.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Genetic Syndromes & Gene Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Genetic Syndromes & Gene Therapy
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Yuk Yin Ng”